Late and very late relapses in acute myeloid leukemia (AML)

Maximilian Stahl^{1

2}, Martin Stuart Tallman^{1

2}

Affiliations

¹ Department of Medicine, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Weill Cornell Medical College, New York, NY, USA.

Comment

Maximilian Stahl et al. Leuk Lymphoma. 2020 May.

. 2020 May;61(5):1010-1011.

doi: 10.1080/10428194.2020.1745204. Epub 2020 Apr 14.

Maximilian Stahl^{1

2}, Martin Stuart Tallman^{1

2}

¹ Department of Medicine, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Weill Cornell Medical College, New York, NY, USA.

No abstract available

Comment on

More than ten percent of relapses occur after five years in AML patients with NPM1 mutation.
Bertoli S, Tavitian S, Bérard E, Mansat-De Mas V, Largeaud L, Gadaud N, Rieu JB, Vergez F, Luquet I, Huguet F, Sarry A, Delabesse E, Récher C. Bertoli S, et al. Leuk Lymphoma. 2020 May;61(5):1226-1229. doi: 10.1080/10428194.2019.1706733. Epub 2020 Feb 5. Leuk Lymphoma. 2020. PMID: 32022605 No abstract available.